General Information of This Antigen
Antigen ID
TAR0KPFBI
Antigen Name
CD70 antigen (CD70)
Gene Name
CD70
Gene ID
970
Synonym
CD27L; CD27LG; TNFSF7; CD27 ligand;Tumor necrosis factor ligand superfamily member 7;CD_antigen=CD70
Sequence
MPEEGSGCSVRRRPYGCVLRAALVPLVAGLVICLVVCIQRFAQAQQQLPLESLGWDVAEL
QLNHTGPQQDPRLYWQGGPALGRSFLHGPELDKGQLRIHRDGIYMVHIQVTLAICSSTTA
SRHHPTTLAVGICSPASRSISLLRLSFHQGCTIASQRLTPLARGDTLCTNLTGTLLPSRN
TDETFFGVQWVRP

    Click to Show/Hide
Family
Tumor necrosis factor family
Function
Cytokine which is the ligand for CD27. The CD70-CD27 pathway plays an important role in the generation and maintenance of T cell immunity, in particular during antiviral responses. Upon CD27 binding, induces the proliferation of costimulated T-cells and enhances the generation of cytolytic T-cells.

    Click to Show/Hide
Uniprot Entry
CD70_HUMAN
HGNC ID
HGNC:11937
KEGG ID
hsa:970
Each Antibody-drug Conjuate AND It's Component Related to This Antigen
Full List of The ADC Related to This Antigen
Anti-CD70 AMG172 mAb
ADC Info ADC Name Payload Target Linker Ref
AMG-172
Mertansine DM1
Microtubule (MT)
Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)
[1]
Anti-CD70 mAb
ADC Info ADC Name Payload Target Linker Ref
Anti-CD70-45 ADC
Tetrahydroisoquinoline-based PBD dimer 17
Human Deoxyribonucleic acid (hDNA)
Mc-Val-Cit-PABC
[2]
Anti-CD70 mAb 1F4
ADC Info ADC Name Payload Target Linker Ref
Anti-CD70 mAb 1F4-IIIa-01
Anti-CD70 mAb 1F4-IIIa-01 payload
Undisclosed
Anti-CD70 mAb 1F4-IIIa-01 linker
[3]
Anti-CD70 mAb 1F4-IIIa-02
Anti-CD70 mAb 1F4-IIIa-02 payload
Undisclosed
Anti-CD70 mAb 1F4-IIIa-02 linker
[3]
Anti-CD70 mAb 1F4-IIIa-03
Anti-CD70 mAb 1F4-IIIa-03 payload
Undisclosed
Anti-CD70 mAb 1F4-IIIa-03 linker
[3]
Anti-CD70 mAb 1F4-IIIa-04
Anti-CD70 mAb 1F4-IIIa-04 payload
Undisclosed
Anti-CD70 mAb 1F4-IIIa-04 linker
[3]
Anti-CD70 mAb 1F4-IIIa-05
Anti-CD70 mAb 1F4-IIIa-05 payload
Undisclosed
Anti-CD70 mAb 1F4-IIIa-05 linker
[3]
Anti-CD70 mAb 1F4-IIIa-06
Anti-CD70 mAb 1F4-IIIa-06 payload
Undisclosed
Anti-CD70 mAb 1F4-IIIa-06 linker
[3]
Anti-CD70 mAb 1F4-IIIa-07
Anti-CD70 mAb 1F4-IIIa-07 payload
Undisclosed
Anti-CD70 mAb 1F4-IIIa-07 linker
[3]
Anti-CD70 mAb 1F4-IIIa-08
Anti-CD70 mAb 1F4-IIIa-08 payload
Undisclosed
Anti-CD70 mAb 1F4-IIIa-08 linker
[3]
Anti-CD70 mAb 1F4-IIIb-01
Anti-CD70 mAb 1F4-IIIb-01 payload
Undisclosed
Anti-CD70 mAb 1F4-IIIb-01 linker
[3]
Anti-CD70 mAb 1F4-IIIb-02
Anti-CD70 mAb 1F4-IIIb-02 payload
Undisclosed
Anti-CD70 mAb 1F4-IIIb-02 linker
[3]
Anti-CD70 mAb 1F4-IIIb-03
Anti-CD70 mAb 1F4-IIIb-03 payload
Undisclosed
Anti-CD70 mAb 1F4-IIIb-03 linker
[3]
Anti-CD70 mAb 1F4-IIIb-04
Anti-CD70 mAb 1F4-IIIb-04 payload
Undisclosed
Anti-CD70 mAb 1F4-IIIb-04 linker
[3]
Anti-CD70 mAb 1F4-IIIb-05
Anti-CD70 mAb 1F4-IIIb-05 payload
Undisclosed
Anti-CD70 mAb 1F4-IIIb-05 linker
[3]
Anti-CD70 mAb 1F4-IIIb-06
Anti-CD70 mAb 1F4-IIIb-06 payload
Undisclosed
Anti-CD70 mAb 1F4-IIIb-06 linker
[3]
Anti-CD70 mAb 1F4-IIIb-07
Anti-CD70 mAb 1F4-IIIb-07 payload
Undisclosed
Anti-CD70 mAb 1F4-IIIb-07 linker
[3]
Anti-CD70 mAb 1F4-IIIb-08
Anti-CD70 mAb 1F4-IIIb-08 payload
Undisclosed
Anti-CD70 mAb 1F4-IIIb-08 linker
[3]
Anti-CD70 mAb 1F4-IIIb-09
Anti-CD70 mAb 1F4-IIIb-09 payload
Undisclosed
Anti-CD70 mAb 1F4-IIIb-09 linker
[3]
Anti-CD70 mAb 1F4-IIIc-01
Anti-CD70 mAb 1F4-IIIc-01 payload
Undisclosed
Anti-CD70 mAb 1F4-IIIc-01 linker
[3]
Anti-CD70 mAb 1F4-IIIc-02
Anti-CD70 mAb 1F4-IIIc-02 payload
Undisclosed
Anti-CD70 mAb 1F4-IIIc-02 linker
[3]
Anti-CD70 mAb 1F4-IIIc-03
Anti-CD70 mAb 1F4-IIIc-03 payload
Undisclosed
Anti-CD70 mAb 1F4-IIIc-03 linker
[3]
Anti-CD70 mAb 1F4-IIIc-04
Anti-CD70 mAb 1F4-IIIc-04 payload
Undisclosed
Anti-CD70 mAb 1F4-IIIc-04 linker
[3]
Anti-CD70 mAb 1F4-IIIc-05
Anti-CD70 mAb 1F4-IIIc-05 payload
Undisclosed
Anti-CD70 mAb 1F4-IIIc-05 linker
[3]
Anti-CD70 mAb 1F4-IIIc-06
Anti-CD70 mAb 1F4-IIIc-06 payload
Undisclosed
Anti-CD70 mAb 1F4-IIIc-06 linker
[3]
Anti-CD70 mAb 1F4-IIIc-07
Anti-CD70 mAb 1F4-IIIc-07 payload
Undisclosed
Anti-CD70 mAb 1F4-IIIc-07 linker
[3]
Anti-CD70 mAb 1F4-IIIc-08
Anti-CD70 mAb 1F4-IIIc-08 payload
Undisclosed
Anti-CD70 mAb 1F4-IIIc-08 linker
[3]
Anti-CD70 mAb 1F4-A
Anti-CD70 mAb 1F4-A payload
Undisclosed
Anti-CD70 mAb 1F4 linker
[3]
Anti-CD70 mAb 2H5
ADC Info ADC Name Payload Target Linker Ref
Anti-CD70 ADC 12-2
Anti-CD70 ADC 12-2 payload
Undisclosed
Anti-CD70 ADC 12-2 linker
[4]
Anti-CD70 ADC 2-7
Anti-CD70 ADC 2-7 payload
Undisclosed
Anti-CD70 ADC 2-7 linker
[4]
Anti-CD70 ADC 3-4
Anti-CD70 ADC 3-4 payload
Undisclosed
Anti-CD70 ADC 3-4 linker
[4]
Anti-CD70 ADC 4-3
Anti-CD70 ADC 4-3 payload
Undisclosed
Anti-CD70 ADC 4-3 linker
[4]
Anti-CD70 ADC 5-3
Anti-CD70 ADC 5-3 payload
Undisclosed
Anti-CD70 ADC 5-3 linker
[4]
Anti-CD70 ADC 6-2
Anti-CD70 ADC 6-2 payload
Undisclosed
Anti-CD70 ADC 6-2 linker
[4]
Anti-CD70 ADC 7-1
Anti-CD70 ADC 7-1 payload
Undisclosed
Anti-CD70 ADC 7-1 linker
[4]
Anti-CD70 ADC 8-5
Anti-CD70 ADC 8-5 payload
Undisclosed
Anti-CD70 ADC 8-5 linker
[4]
Anti-CD70 ADC 9-4
Anti-CD70 ADC 9-4 payload
Undisclosed
Anti-CD70 ADC 9-4 linker
[4]
Anti-CD70 ADC 10-1
Anti-CD70 ADC 10-1 payload
Undisclosed
Anti-CD70 ADC 10-1 linker
[4]
Anti-CD70 ADC 11-5
Anti-CD70 ADC 11-5 payload
Undisclosed
Anti-CD70 ADC 11-5 linker
[4]
Anti-CD70 ADC 12-3
Anti-CD70 ADC 12-3 payload
Undisclosed
Anti-CD70 ADC 12-3 linker
[4]
Anti-CD70 ADC 13-7
Anti-CD70 ADC 13-7 payload
Undisclosed
Anti-CD70 ADC 13-7 linker
[4]
Anti-CD70 ADC 14-5
Anti-CD70 ADC 14-5 payload
Undisclosed
Anti-CD70 ADC 14-5 linker
[4]
Anti-CD70 ADC 15-5
Anti-CD70 ADC 15-5 payload
Undisclosed
Anti-CD70 ADC 15-5 linker
[4]
Anti-CD70 ADC 16-5
Anti-CD70 ADC 16-5 payload
Undisclosed
Anti-CD70 ADC 16-5 linker
[4]
Anti-CD70 ADC 17-2
Anti-CD70 ADC 17-2 payload
Undisclosed
Anti-CD70 ADC 17-2 linker
[4]
Anti-CD70 ADC 18-3
Anti-CD70 ADC 18-3 payload
Undisclosed
Anti-CD70 ADC 18-3 linker
[4]
Anti-CD70 ADC 19-5
Anti-CD70 ADC 19-5 payload
Undisclosed
Anti-CD70 ADC 19-5 linker
[4]
Anti-CD70 ADC 21-5
Anti-CD70 ADC 21-5 payload
Undisclosed
Anti-CD70 ADC 21-5 linker
[4]
Anti-CD70 ADC 20-5
Anti-CD70 ADC 20-5 payload
Undisclosed
Anti-CD70 ADC 20-5 linker
[4]
Anti-CD70 mAb c1F6
ADC Info ADC Name Payload Target Linker Ref
WO2007011968A2 c1F6-9a
Monomethyl auristatin E
Microtubule (MT)
WO2007011968A2_c1F6-9a linker
[5]
WO2007011968A2 c1F6-9b
Monomethyl auristatin F
Microtubule (MT)
WO2007011968A2_c1F6-9b linker
[5]
WO2007011968A2 c1F6-17
Doxorubicin
DNA topoisomerase 2-alpha (TOP2A)
WO2007011968A2_c1F6-17 linker
[5]
Anti-CD70 mAb h1F6
ADC Info ADC Name Payload Target Linker Ref
WO2015095755A1 h1F6-1.3
Monomethyl auristatin E
Microtubule (MT)
WO2015095755A1_h1F6-1.3 linker
[6]
WO2015095755A1 h1F6-1006
WO2015095755A1_h1F6-1006 payload
Undisclosed
WO2015095755A1_h1F6-1006 linker
[6]
WO2015095755A1 h1F6-2.0
Monomethyl auristatin E
Microtubule (MT)
WO2015095755A1_h1F6-2.0 linker
[6]
WO2015095755A1 h1F6-5.6
WO2015095755A1_h1F6-5.6 payload
Undisclosed
WO2015095755A1_h1F6-5.6 linker
[6]
WO2015095755A1 h1F6-6.4
WO2015095755A1_h1F6-6.4 payload
Undisclosed
WO2015095755A1_h1F6-6.4 linker
[6]
WO2015095755A1 h1F6-7.7
WO2015095755A1_h1F6-7.7 payload
Undisclosed
WO2015095755A1_h1F6-7.7 linker
[6]
Anti-CD70 mAb humanized 1F6
ADC Info ADC Name Payload Target Linker Ref
h1F6-Compound 1
h1F6-compound 1 payload
Undisclosed
h1F6-compound 1 linker
[7]
h1F6-Compound 2
h1F6-compound 2 payload
Undisclosed
h1F6-compound 2 linker
[7]
h1F6-Compound 3
h1F6-compound 3 payload
Undisclosed
h1F6-compound 3 linker
[7]
Anti-CD70 mAb IF6
ADC Info ADC Name Payload Target Linker Ref
1F6-Val-Cit-PABC-MMAF
Monomethyl auristatin F
Microtubule (MT)
Mal-Val-Cit-PABC
[8]
1F6-Ile-Pro-AF
Auristatin F
Microtubule (MT)
Mal-Ile-Pro
[8]
1F6-Me3-Lys-Pro-AF
Auristatin F
Microtubule (MT)
Mal-Me3Lys-Pro
[8]
1F6-NorVal- (D)Asp-AF
Auristatin F
Microtubule (MT)
Mal-NorVal-D-Asp
[8]
1F6-beta-Ala- (D)Asp-AF
Auristatin F
Microtubule (MT)
Mal-bata-Ala-D-Asp
[8]
1F6-PhenylGly- (D)Lys-AF
Auristatin F
Microtubule (MT)
Mal-PhenylGly-D-Lys
[8]
1F6-Met- (D)Lys-AF
Auristatin F
Microtubule (MT)
Mal-Met-D-Lys
[8]
1F6-Asn- (D)Lys-AM
Auristatin M
Microtubule (MT)
Mal-Asn-D-Lys
[8]
1F6-Met- (D)Lys-AW
L-Alanyl-L-tryptophan
Microtubule (MT)
Mal-Met-D-Lys
[8]
1F6-Ile-Val-AF
Auristatin F
Microtubule (MT)
Mal-Ile-Val
[8]
1F6-Asp-Val-AF
Auristatin F
Microtubule (MT)
Mal-Asp-Val
[8]
1F6-His-Val-AF
Auristatin F
Microtubule (MT)
Mal-His-Val
[8]
1F6-Met-Lys-AF
Auristatin F
Microtubule (MT)
Mal-Met-Lys
[8]
1F6-Asn-Lys-AF
Auristatin F
Microtubule (MT)
Mal-Asn-Lys
[8]
1F6-Pro- (D)Lys-AF
Auristatin F
Microtubule (MT)
Mal-Pro-D-Lys
[8]
1F6-Met- (D)Lys-MMAF
Monomethyl auristatin F
Microtubule (MT)
Mal-Met-D-Lys
[8]
1F6-Asn- (D)Lys-MMAF
Monomethyl auristatin F
Microtubule (MT)
Mal-Asn-D-Lys
[8]
1F6-Met- (D)Lys-AM
Auristatin M
Microtubule (MT)
Mal-Met-D-Lys
[8]
1F6-Asn- (D)Lys-AW
L-Alanyl-L-tryptophan
Microtubule (MT)
Mal-Asn-D-Lys
[8]
1F6-Asn- (D)Lys-AF
Auristatin F
Microtubule (MT)
Mal-Asn-D-Lys
[8]
Anti-CD70 mAb murine 1F6
ADC Info ADC Name Payload Target Linker Ref
m1F6-Compound 1
m1F6-compound 1 payload
Undisclosed
m1F6-compound 1 linker
[7]
m1F6-Compound 2
m1F6-compound 2 payload
Undisclosed
m1F6-compound 2 linker
[7]
m1F6-Compound 3
m1F6-compound 3 payload
Undisclosed
m1F6-compound 3 linker
[7]
Chimeric Anti-CD70 Anti-ody
ADC Info ADC Name Payload Target Linker Ref
Alpha-CD70-Mc-MMAF
Monomethyl auristatin E
Microtubule (MT)
Mc-Val-Cit-PABC
[9]
ADC Info ADC Name Payload Target Linker Ref
MDX-1203
Seco-MED-A
Human Deoxyribonucleic acid (hDNA)
Mal-Val-Cit
[10]
Vorsetuzumab
ADC Info ADC Name Payload Target Linker Ref
CD70-MMAF-ADC
Monomethyl auristatin F
Microtubule (MT)
Maleimido-caproyl
[11]
h1F6-mcMMAF
Monomethyl auristatin F
Microtubule (MT)
Maleimido-caproyl
[12]
h1F6-MC-vc-PABC-MMAE
Monomethyl auristatin E
Microtubule (MT)
Mc-Val-Cit-PABC
[12]
h1F6-MC-vc-PABC-MMAF DAR4
Monomethyl auristatin E
Microtubule (MT)
Mc-Val-Cit-PABC
[12]
h1F6-1 MMAE DAR4
Monomethyl auristatin E
Microtubule (MT)
Phe-Dpr-MA
[12]
h1F6-1 MMAE DAR8
Monomethyl auristatin E
Microtubule (MT)
Phe-Dpr-MA
[12]
h1F6-2 MMAE DAR4
Monomethyl auristatin E
Microtubule (MT)
Phe-Glu-Dpr-MA
[12]
h1F6-2 MMAE DAR8
Monomethyl auristatin E
Microtubule (MT)
Phe-Glu-Dpr-MA
[12]
h1F6-3 MMAE DAR4
Monomethyl auristatin E
Microtubule (MT)
Thr-Dpr-MA
[12]
h1F6-3 MMAE DAR8
Monomethyl auristatin E
Microtubule (MT)
Thr-Dpr-MA
[12]
h1F6-4 MMAE DAR4
Monomethyl auristatin E
Microtubule (MT)
Thr-Glu-Dpr-MA
[12]
h1F6-4 MMAE DAR8
Monomethyl auristatin E
Microtubule (MT)
Thr-Glu-Dpr-MA
[12]
h1F6-5 MMAE DAR4
Monomethyl auristatin E
Microtubule (MT)
Phe-Glu-Dpr-MDpr
[12]
h1F6-5 MMAE DAR8
Monomethyl auristatin E
Microtubule (MT)
Phe-Glu-Dpr-MDpr
[12]
h1F6-6 MMAE DAR4
Monomethyl auristatin E
Microtubule (MT)
Thr-Glu-Dpr-MDpr
[12]
h1F6-6 MMAE DAR8
Monomethyl auristatin E
Microtubule (MT)
Thr-Glu-Dpr-MDpr
[12]
h1F6-7 MMAE DAR4
Monomethyl auristatin E
Microtubule (MT)
Thr-Glu-Lys-MDpr
[12]
h1F6-7 MMAE DAR8
Monomethyl auristatin E
Microtubule (MT)
Thr-Glu-Lys-MDpr
[12]
h1F6-8 MMAE
Monomethyl auristatin E
Microtubule (MT)
Thiazole-Glu-Lys-MDpr
[12]
h1F6-9 MMAE
Monomethyl auristatin E
Microtubule (MT)
Phe-Glu-EDA-MDpr
[12]
h1F6-10 MMAE
Monomethyl auristatin E
Microtubule (MT)
Thr-Glu-EDA-MDpr
[12]
h1F6-11 MMAE
Monomethyl auristatin E
Microtubule (MT)
Phe-Ile-EDA-MDpr
[12]
h1F6-12 MMAE DAR4
Monomethyl auristatin E
Microtubule (MT)
Thr-Ile-EDA-MDpr
[12]
h1F6-13 MMAE DAR4
Monomethyl auristatin E
Microtubule (MT)
Thiazole-Glu-EDA-MDpr
[12]
h1F6-14 MMAE
Monomethyl auristatin E
Microtubule (MT)
Asp-Ala-Lys-MDpr
[12]
h1F6-15 MMAE
Monomethyl auristatin E
Microtubule (MT)
Glu-Ala-Lys-MDpr
[12]
h1F6-16 MMAE
Monomethyl auristatin E
Microtubule (MT)
PhosphoThr-Ala-Lys-MDpr
[12]
h1F6-17 MMAE
Monomethyl auristatin E
Microtubule (MT)
Asn-AlaGlu-Dpr-MDpr
[12]
h1F6-18 MMAE
Monomethyl auristatin E
Microtubule (MT)
Glu-Ala-Glu-Dpr-MDpr
[12]
h1F6-19 MMAE
Monomethyl auristatin E
Microtubule (MT)
Asp-AlaGlu-Dpr-MDpr
[12]
h1F6-20 MMAE
Monomethyl auristatin E
Microtubule (MT)
Glu-Ala-Glu-Dpr-MDpr
[12]
h1F6-21 MMAE
Monomethyl auristatin E
Microtubule (MT)
hSer-Ala-Glu-Dpr-MDpr
[12]
h1F6-22 MMAE
Monomethyl auristatin E
Microtubule (MT)
ValoH-AlaGlu-Dpr-MDpr
[12]
h1F6-23 MMAE
Monomethyl auristatin E
Microtubule (MT)
PhosphoThr-Ala-Glu-Dpr-MDpr
[12]
h1F6-24 MMAE
Monomethyl auristatin E
Microtubule (MT)
Pyrazole-Glu-Dpr-MDpr
[12]
h1F6-25 MMAE
Monomethyl auristatin E
Microtubule (MT)
Triazole-Glu-Dpr-MDpr
[12]
h1F6-26 MMAE
Monomethyl auristatin E
Microtubule (MT)
Asn-Glu-Dpr-MDpr
[12]
h1F6-27 MMAE
Monomethyl auristatin E
Microtubule (MT)
Asp-Glu-Dpr-MDpr
[12]
h1F6-28 MMAE
Monomethyl auristatin E
Microtubule (MT)
Fur-Glu-Dpr-MDpr
[12]
h1F6-29 MMAE
Monomethyl auristatin E
Microtubule (MT)
ValOH-Glu-Dpr-MDpr
[12]
h1F6-30 MMAE
Monomethyl auristatin E
Microtubule (MT)
Ser-Glu-Dpr-MDpr
[12]
h1F6-31 MMAE
Monomethyl auristatin E
Microtubule (MT)
hSer-Glu-Dpr-MDpr
[12]
h1F6-32 MMAE
Monomethyl auristatin E
Microtubule (MT)
Thr-IleLeu-Dpr-MDpr
[12]
h1F6-33 MMAE
Monomethyl auristatin E
Microtubule (MT)
Phe-Ile-Leu-Dpr-MDpr
[12]
h1F6-34 MMAE
Monomethyl auristatin E
Microtubule (MT)
Glu-Phe-Leu-Dpr-MDpr
[12]
h1F6-35 MMAE
Monomethyl auristatin E
Microtubule (MT)
Thr-LeuPhe-Dpr-MDpr
[12]
h1F6-36 MMAE
Monomethyl auristatin E
Microtubule (MT)
Phe-Leu-Phe-Dpr-MDpr
[12]
h1F6-37 MMAE
Monomethyl auristatin E
Microtubule (MT)
Glu-Phe-Phe-Dpr-MDpr
[12]
h1F6-38 MMAE
Monomethyl auristatin E
Microtubule (MT)
Thr-LysAla-Dpr-MDpr
[12]
h1F6-39 MMAE
Monomethyl auristatin E
Microtubule (MT)
Thr-Lys-Dpr-MDpr
[12]
h1F6-1 MMAF
Monomethyl auristatin F
Microtubule (MT)
Phe-Dpr-MA
[12]
h1F6-2 MMAF
Monomethyl auristatin F
Microtubule (MT)
Phe-Glu-Dpr-MA
[12]
h1F6-3 MMAF
Monomethyl auristatin F
Microtubule (MT)
Thr-Dpr-MA
[12]
h1F6-4 MMAF
Monomethyl auristatin F
Microtubule (MT)
Thr-Glu-Dpr-MA
[12]
h1F6-5 MMAF
Monomethyl auristatin F
Microtubule (MT)
Phe-Glu-Dpr-MDpr
[12]
h1F6-6 MMAF
Monomethyl auristatin F
Microtubule (MT)
Thr-Glu-Dpr-MDpr
[12]
h1F6-7 MMAF
Monomethyl auristatin F
Microtubule (MT)
Thr-Glu-Lys-MDpr
[12]
h1F6-8 MMAF
Monomethyl auristatin F
Microtubule (MT)
Thiazole-Glu-Lys-MDpr
[12]
h1F6-9 MMAF
Monomethyl auristatin F
Microtubule (MT)
Phe-Glu-EDA-MDpr
[12]
h1F6-10 MMAF
Monomethyl auristatin F
Microtubule (MT)
Thr-Glu-EDA-MDpr
[12]
h1F6-11 MMAF
Monomethyl auristatin F
Microtubule (MT)
Phe-Ile-EDA-MDpr
[12]
h1F6-12 MMAF
Monomethyl auristatin F
Microtubule (MT)
Thr-Ile-EDA-MDpr
[12]
h1F6-13 MMAF
Monomethyl auristatin F
Microtubule (MT)
Thiazole-Glu-EDA-MDpr
[12]
h1F6-14 MMAF
Monomethyl auristatin F
Microtubule (MT)
Asp-Ala-Lys-MDpr
[12]
h1F6-15 MMAF
Monomethyl auristatin F
Microtubule (MT)
Glu-Ala-Lys-MDpr
[12]
h1F6-16 MMAF
Monomethyl auristatin F
Microtubule (MT)
PhosphoThr-Ala-Lys-MDpr
[12]
h1F6-17 MMAF
Monomethyl auristatin F
Microtubule (MT)
Asn-AlaGlu-Dpr-MDpr
[12]
h1F6-18 MMAF
Monomethyl auristatin F
Microtubule (MT)
Glu-Ala-Glu-Dpr-MDpr
[12]
h1F6-19 MMAF
Monomethyl auristatin F
Microtubule (MT)
Asp-AlaGlu-Dpr-MDpr
[12]
h1F6-20 MMAF
Monomethyl auristatin F
Microtubule (MT)
Glu-Ala-Glu-Dpr-MDpr
[12]
h1F6-21 MMAF
Monomethyl auristatin F
Microtubule (MT)
hSer-Ala-Glu-Dpr-MDpr
[12]
h1F6-22 MMAF
Monomethyl auristatin F
Microtubule (MT)
ValoH-AlaGlu-Dpr-MDpr
[12]
h1F6-23 MMAF
Monomethyl auristatin F
Microtubule (MT)
PhosphoThr-Ala-Glu-Dpr-MDpr
[12]
h1F6-24 MMAF
Monomethyl auristatin F
Microtubule (MT)
Pyrazole-Glu-Dpr-MDpr
[12]
h1F6-25 MMAF
Monomethyl auristatin F
Microtubule (MT)
Triazole-Glu-Dpr-MDpr
[12]
h1F6-26 MMAF
Monomethyl auristatin F
Microtubule (MT)
Asn-Glu-Dpr-MDpr
[12]
h1F6-27 MMAF
Monomethyl auristatin F
Microtubule (MT)
Asp-Glu-Dpr-MDpr
[12]
h1F6-28 MMAF
Monomethyl auristatin F
Microtubule (MT)
Fur-Glu-Dpr-MDpr
[12]
h1F6-29 MMAF
Monomethyl auristatin F
Microtubule (MT)
ValOH-Glu-Dpr-MDpr
[12]
h1F6-30 MMAF
Monomethyl auristatin F
Microtubule (MT)
Ser-Glu-Dpr-MDpr
[12]
h1F6-31 MMAF
Monomethyl auristatin F
Microtubule (MT)
hSer-Glu-Dpr-MDpr
[12]
h1F6-32 MMAF
Monomethyl auristatin F
Microtubule (MT)
Thr-IleLeu-Dpr-MDpr
[12]
h1F6-33 MMAF
Monomethyl auristatin F
Microtubule (MT)
Phe-Ile-Leu-Dpr-MDpr
[12]
h1F6-34 MMAF
Monomethyl auristatin F
Microtubule (MT)
Glu-Phe-Leu-Dpr-MDpr
[12]
h1F6-35 MMAF
Monomethyl auristatin F
Microtubule (MT)
Thr-LeuPhe-Dpr-MDpr
[12]
h1F6-36 MMAF
Monomethyl auristatin F
Microtubule (MT)
Phe-Leu-Phe-Dpr-MDpr
[12]
h1F6-37 MMAF
Monomethyl auristatin F
Microtubule (MT)
Glu-Phe-Phe-Dpr-MDpr
[12]
h1F6-38 MMAF
Monomethyl auristatin F
Microtubule (MT)
Thr-LysAla-Dpr-MDpr
[12]
h1F6-39 MMAF
Monomethyl auristatin F
Microtubule (MT)
Thr-Lys-Dpr-MDpr
[12]
h1F6-MC-vc-PABC-MMAF DAR8
Monomethyl auristatin E
Microtubule (MT)
Mc-Val-Cit-PABC
[12]
h1F6-13 MMAE DAR8
Monomethyl auristatin E
Microtubule (MT)
Thiazole-Glu-EDA-MDpr
[12]
h1F6-12 MMAE DAR8
Monomethyl auristatin E
Microtubule (MT)
Thr-Ile-EDA-MDpr
[12]
h1F6-11 MMAE DAR8
Monomethyl auristatin E
Microtubule (MT)
Phe-Ile-EDA-MDpr
[12]
h1F6-17 MMAE DAR4
Monomethyl auristatin E
Microtubule (MT)
Asn-AlaGlu-Dpr-MDpr
[12]
h1F6-20 MMAE DAR4
Monomethyl auristatin E
Microtubule (MT)
Glu-Ala-Glu-Dpr-MDpr
[12]
h1F6-24 MMAE DAR4
Monomethyl auristatin E
Microtubule (MT)
Pyrazole-Glu-Dpr-MDpr
[12]
h1F6-29 MMAE DAR4
Monomethyl auristatin E
Microtubule (MT)
ValOH-Glu-Dpr-MDpr
[12]
Vorsetuzumab mafodotin
Monomethyl auristatin F
Microtubule (MT)
Maleimido-caproyl
[13]
Undisclosed
ADC Info ADC Name Payload Target Linker Ref
PRO-1160
Exatecan
DNA topoisomerase 1 (TOP1)
Cys-11 ADC linker
[14]
ARX-305
Undisclosed
Undisclosed
Undisclosed
[15]
CD70-glucocorticoid ADC
Fluticasone propionate
Glucocorticoid receptor (NR3C1)
Pyrophosphate linker
[16]
Anti-CD70 antibody-drug conjugate (XDCExplorer)
Undisclosed
Undisclosed
Undisclosed
[17]
SGN-CD70A
PBD dimer
Human Deoxyribonucleic acid (hDNA)
Undisclosed
[18]
Tissue/Disease specific Abundances of This Antigen
Tissue specific Abundances of This Antigen
ICD Disease Classification 01
Click to Show/Hide the 1 Disease of This Class
Bacterial infection [ICD-11: 1A00-1C4Z]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Gingival
The Specific Disease Bacterial infection of gingival
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 5.37E-09; Fold-change: 0.23750405; Z-score: 0.833646569
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
ICD Disease Classification 02
Click to Show/Hide the 22 Disease of This Class
Brain cancer [ICD-11: 2A00]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Brainstem
The Specific Disease Glioma
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.944591191; Fold-change: -0.124328097; Z-score: -0.623539676
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
The Studied Tissue White matter
The Specific Disease Glioma
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.296821774; Fold-change: 0.008460034; Z-score: 0.0275707
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
The Studied Tissue Brainstem
The Specific Disease Neuroectodermal tumor
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.107396488; Fold-change: -0.240458099; Z-score: -0.760507704
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
The Studied Tissue Nervous
The Specific Disease Brain cancer
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 1.22E-24; Fold-change: -0.201168492; Z-score: -0.780207153
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Chronic myeloid leukemia [ICD-11: 2A20]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Whole blood
The Specific Disease Polycythemia vera
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.256904399; Fold-change: 0.028415902; Z-score: 0.151097969
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
The Studied Tissue Whole blood
The Specific Disease Myelofibrosis
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.639824598; Fold-change: 0.052777286; Z-score: 0.307799235
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
MyeloDysplastic syndromes [ICD-11: 2A37]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Bone marrow
The Specific Disease Myelodysplastic syndromes
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.685058632; Fold-change: -0.015234703; Z-score: -0.069104482
The Expression Level of Disease Section Compare with the Adjacent Tissue p-value: 0.06928947; Fold-change: -0.279343794; Z-score: -1.509558407
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Lymphoma [ICD-11: 2A90- 2A85]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Tonsil
The Specific Disease Lymphoma
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.03297748; Fold-change: -0.381742447; Z-score: -0.903711874
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Gastric cancer [ICD-11: 2B72]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Gastric
The Specific Disease Gastric cancer
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.634430958; Fold-change: -0.165798519; Z-score: -1.301898
The Expression Level of Disease Section Compare with the Adjacent Tissue p-value: 0.599070617; Fold-change: 0.05906427; Z-score: 0.131697646
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Colon cancer [ICD-11: 2B90]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Colon
The Specific Disease Colon cancer
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 1.24E-06; Fold-change: 0.094885138; Z-score: 0.422294857
The Expression Level of Disease Section Compare with the Adjacent Tissue p-value: 0.008232536; Fold-change: 0.064131693; Z-score: 0.231928031
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Pancreatic cancer [ICD-11: 2C10]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Pancreas
The Specific Disease Pancreatic cancer
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.154293126; Fold-change: -0.087780047; Z-score: -0.193735315
The Expression Level of Disease Section Compare with the Adjacent Tissue p-value: 5.29E-09; Fold-change: -0.412074412; Z-score: -0.845854312
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Liver cancer [ICD-11: 2C12]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Liver
The Specific Disease Liver cancer
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 5.75E-10; Fold-change: -0.283005949; Z-score: -1.249430279
The Expression Level of Disease Section Compare with the Adjacent Tissue p-value: 1.04E-18; Fold-change: -0.209691996; Z-score: -0.848284074
The Expression Level of Disease Section Compare with the Other Disease Section p-value: 0.059981678; Fold-change: -0.350218619; Z-score: -1.548397323
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Lung cancer [ICD-11: 2C25]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Lung
The Specific Disease Lung cancer
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.553534995; Fold-change: 0.041268023; Z-score: 0.134326403
The Expression Level of Disease Section Compare with the Adjacent Tissue p-value: 0.003968516; Fold-change: 0.032888585; Z-score: 0.123779959
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Melanoma [ICD-11: 2C30]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Skin
The Specific Disease Melanoma
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.743977343; Fold-change: -0.175865047; Z-score: -0.427961713
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Sarcoma [ICD-11: 2C35]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Muscle
The Specific Disease Sarcoma
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.000451932; Fold-change: -0.145394142; Z-score: -0.404159227
The Expression Level of Disease Section Compare with the Adjacent Tissue p-value: 0.022315819; Fold-change: -0.347372729; Z-score: -2.68782675
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Breast cancer [ICD-11: 2C60]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Breast
The Specific Disease Breast cancer
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.885048994; Fold-change: 0.085923668; Z-score: 0.212718805
The Expression Level of Disease Section Compare with the Adjacent Tissue p-value: 0.71651679; Fold-change: 0.091508804; Z-score: 0.27284419
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Ovarian cancer [ICD-11: 2C73]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Ovarian
The Specific Disease Ovarian cancer
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.813029236; Fold-change: 0.009587821; Z-score: 0.030097291
The Expression Level of Disease Section Compare with the Adjacent Tissue p-value: 2.87E-06; Fold-change: 0.266657282; Z-score: 1.702349205
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Cervical cancer [ICD-11: 2C77]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Cervical
The Specific Disease Cervical cancer
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 8.07E-08; Fold-change: 0.219803323; Z-score: 1.338098708
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Uterine cancer [ICD-11: 2C78]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Endometrium
The Specific Disease Uterine cancer
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 1.69E-18; Fold-change: 0.30938461; Z-score: 1.041461445
The Expression Level of Disease Section Compare with the Adjacent Tissue p-value: 0.015320501; Fold-change: 0.071001107; Z-score: 0.71137971
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Prostate cancer [ICD-11: 2C82]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Prostate
The Specific Disease Prostate cancer
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.000128867; Fold-change: -0.529515252; Z-score: -1.524134541
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Bladder cancer [ICD-11: 2C94]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Bladder
The Specific Disease Bladder cancer
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.240056403; Fold-change: 0.100707108; Z-score: 0.671577104
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Retina cancer [ICD-11: 2D02]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Uvea
The Specific Disease Retinoblastoma tumor
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.128374573; Fold-change: 0.129806686; Z-score: 0.911268646
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Thyroid cancer [ICD-11: 2D10]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Thyroid
The Specific Disease Thyroid cancer
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 3.60E-09; Fold-change: 0.174188158; Z-score: 0.526053819
The Expression Level of Disease Section Compare with the Adjacent Tissue p-value: 1.74E-13; Fold-change: 0.224938282; Z-score: 1.337005465
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Adrenal cancer [ICD-11: 2D11]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Adrenal cortex
The Specific Disease Adrenocortical carcinoma
The Expression Level of Disease Section Compare with the Other Disease Section p-value: 0.638833026; Fold-change: -0.026805528; Z-score: -0.190257033
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Head and neck cancer [ICD-11: 2D42]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Head and neck
The Specific Disease Head and neck cancer
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 6.74E-12; Fold-change: 0.268481975; Z-score: 0.958367452
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Pituitary cancer [ICD-11: 2F37]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Pituitary
The Specific Disease Pituitary gonadotrope tumor
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.445422064; Fold-change: -0.026463497; Z-score: -0.145436792
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
The Studied Tissue Pituitary
The Specific Disease Pituitary cancer
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.049324001; Fold-change: 0.057461193; Z-score: 0.289861841
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
ICD Disease Classification 03
Click to Show/Hide the 1 Disease of This Class
Thrombocytopenia [ICD-11: 3B64]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Whole blood
The Specific Disease Thrombocytopenia
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.676480355; Fold-change: 0.041811326; Z-score: 0.068350163
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
ICD Disease Classification 04
Click to Show/Hide the 2 Disease of This Class
Lupus erythematosus [ICD-11: 4A40]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Whole blood
The Specific Disease Lupus erythematosus
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.421348307; Fold-change: 0.012197138; Z-score: 0.02482372
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Autoimmune disease [ICD-11: 4A4Z]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Peripheral monocyte
The Specific Disease Autoimmune uveitis
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.107819953; Fold-change: -0.161364812; Z-score: -2.031869674
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
ICD Disease Classification 05
Click to Show/Hide the 1 Disease of This Class
Hyperlipoproteinaemia [ICD-11: 5C80]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Whole blood
The Specific Disease Familial hypercholesterolemia
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.034517818; Fold-change: -0.188379494; Z-score: -0.652847613
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
ICD Disease Classification 06
Click to Show/Hide the 1 Disease of This Class
Schizophrenia [ICD-11: 6A20]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Superior temporal cortex
The Specific Disease Schizophrenia
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.325489898; Fold-change: 0.00289254; Z-score: 0.021550329
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
ICD Disease Classification 08
Click to Show/Hide the 3 Disease of This Class
Multiple sclerosis [ICD-11: 8A40]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Spinal cord
The Specific Disease Multiple sclerosis
The Expression Level of Disease Section Compare with the Adjacent Tissue p-value: 0.181533279; Fold-change: -0.066263277; Z-score: -0.897859436
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
The Studied Tissue Plasmacytoid dendritic cells
The Specific Disease Multiple sclerosis
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.179794171; Fold-change: 0.109279428; Z-score: 0.456649907
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Epilepsy [ICD-11: 8A60]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Peritumoral cortex
The Specific Disease Epilepsy
The Expression Level of Disease Section Compare with the Other Disease Section p-value: 0.921399797; Fold-change: -0.063190059; Z-score: -0.359965999
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Cerebral ischaemic stroke [ICD-11: 8B11]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Whole blood
The Specific Disease Cardioembolic Stroke
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.028592619; Fold-change: -0.102468728; Z-score: -0.600367449
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
The Studied Tissue Peripheral blood
The Specific Disease Ischemic stroke
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.054246247; Fold-change: -0.0683143; Z-score: -0.419415852
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
ICD Disease Classification 1
Click to Show/Hide the 6 Disease of This Class
HIV [ICD-11: 1C60-1C62]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue White matter
The Specific Disease HIV
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.650052834; Fold-change: -0.016599487; Z-score: -0.157926573
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Influenza [ICD-11: 1E30]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Whole blood
The Specific Disease Influenza
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.098930452; Fold-change: 0.462346823; Z-score: 1.240312163
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Chronic hepatitis C [ICD-11: 1E51.1]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Whole blood
The Specific Disease Chronic hepatitis C
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.855587537; Fold-change: 0.044065782; Z-score: 0.178161975
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Sepsis [ICD-11: 1G40-1G41]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Whole blood
The Specific Disease Sepsis
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.401187587; Fold-change: -0.025202715; Z-score: -0.098670256
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Septic shock [ICD-11: 1G41]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Whole blood
The Specific Disease Septic shock
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.478968668; Fold-change: -0.022392567; Z-score: -0.086589329
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Pediatric respiratory syncytial virus infection [ICD-11: CA40.11]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Peripheral blood
The Specific Disease Pediatric respiratory syncytial virus infection
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.592109307; Fold-change: 0.030463482; Z-score: 0.206999056
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
ICD Disease Classification 11
Click to Show/Hide the 6 Disease of This Class
Essential hypertension [ICD-11: BA00]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Peripheral blood
The Specific Disease Essential hypertension
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.214990384; Fold-change: 0.39378589; Z-score: 1.499472431
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Myocardial infarction [ICD-11: BA41]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Peripheral blood
The Specific Disease Myocardial infarction
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.341724863; Fold-change: 0.165425348; Z-score: 0.322484785
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Coronary artery disease [ICD-11: BA8Z]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Peripheral blood
The Specific Disease Coronary artery disease
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.498161652; Fold-change: -0.112685735; Z-score: -0.547068076
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Aortic stenosis [ICD-11: BB70]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Calcified aortic valve
The Specific Disease Aortic stenosis
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.259719701; Fold-change: 0.057464388; Z-score: 0.202998545
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Arteriosclerosis [ICD-11: BD40]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Peripheral blood
The Specific Disease Arteriosclerosis
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.065366303; Fold-change: 0.090565972; Z-score: 0.462078942
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Aneurysm [ICD-11: BD50]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Intracranial artery
The Specific Disease Aneurysm
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.647587712; Fold-change: -0.088139256; Z-score: -0.305972652
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
ICD Disease Classification 12
Click to Show/Hide the 8 Disease of This Class
Immunodeficiency [ICD-11: 4A00-4A20]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Peripheral blood
The Specific Disease Immunodeficiency
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.237691864; Fold-change: 0.117713429; Z-score: 0.947907172
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Apnea [ICD-11: 7A40]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Hyperplastic tonsil
The Specific Disease Apnea
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.10858373; Fold-change: -0.202455955; Z-score: -0.994942514
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Olive pollen allergy [ICD-11: CA08.00]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Peripheral blood
The Specific Disease Olive pollen allergy
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.006472113; Fold-change: 0.260031861; Z-score: 3.373450789
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Chronic rhinosinusitis [ICD-11: CA0A]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Sinus mucosa
The Specific Disease Chronic rhinosinusitis
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.033692129; Fold-change: 0.101551121; Z-score: 0.71789763
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Chronic obstructive pulmonary disease [ICD-11: CA22]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Lung
The Specific Disease Chronic obstructive pulmonary disease
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.288189846; Fold-change: 0.105397164; Z-score: 0.448875397
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
The Studied Tissue Small airway epithelium
The Specific Disease Chronic obstructive pulmonary disease
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 6.35E-05; Fold-change: 0.209170532; Z-score: 0.969029734
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Asthma [ICD-11: CA23]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Nasal and bronchial airway
The Specific Disease Asthma
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.552177907; Fold-change: -0.057484319; Z-score: -0.230938717
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Human rhinovirus infection [ICD-11: CA42]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Nasal Epithelium
The Specific Disease Human rhinovirus infection
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.917896705; Fold-change: -0.022405905; Z-score: -0.201375919
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Idiopathic pulmonary fibrosis [ICD-11: CB03.4]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Lung
The Specific Disease Idiopathic pulmonary fibrosis
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.185426239; Fold-change: -0.181575027; Z-score: -1.106974531
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
ICD Disease Classification 13
Click to Show/Hide the 5 Disease of This Class
Periodontal disease [ICD-11: DA0C]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Gingival
The Specific Disease Periodontal disease
The Expression Level of Disease Section Compare with the Adjacent Tissue p-value: 1.07E-09; Fold-change: 0.221882032; Z-score: 0.844108601
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Eosinophilic gastritis [ICD-11: DA42.2]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Gastric antrum
The Specific Disease Eosinophilic gastritis
The Expression Level of Disease Section Compare with the Adjacent Tissue p-value: 0.021676621; Fold-change: 0.135963038; Z-score: 1.801565879
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Liver failure [ICD-11: DB99.7-DB99.8]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Liver
The Specific Disease Liver failure
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.068424499; Fold-change: -0.132991049; Z-score: -0.796388136
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Ulcerative colitis [ICD-11: DD71]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Colon mucosal
The Specific Disease Ulcerative colitis
The Expression Level of Disease Section Compare with the Adjacent Tissue p-value: 0.896623955; Fold-change: 0.162674831; Z-score: 0.415945862
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Irritable bowel syndrome [ICD-11: DD91.0]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Rectal colon
The Specific Disease Irritable bowel syndrome
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.677179844; Fold-change: 0.000165601; Z-score: 0.000871468
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
ICD Disease Classification 14
Click to Show/Hide the 5 Disease of This Class
Atopic dermatitis [ICD-11: EA80]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Skin
The Specific Disease Atopic dermatitis
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.079279291; Fold-change: -0.090628259; Z-score: -0.616771124
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Psoriasis [ICD-11: EA90]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Skin
The Specific Disease Psoriasis
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 4.92E-14; Fold-change: -0.497514186; Z-score: -0.974353583
The Expression Level of Disease Section Compare with the Adjacent Tissue p-value: 6.17E-14; Fold-change: 0.704554845; Z-score: 1.789309817
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Vitiligo [ICD-11: ED63.0]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Skin
The Specific Disease Vitiligo
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.226227075; Fold-change: 0.252847427; Z-score: 0.615901171
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Alopecia [ICD-11: ED70]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Skin from scalp
The Specific Disease Alopecia
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.583909856; Fold-change: 0.023311594; Z-score: 0.122729509
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Sensitive skin [ICD-11: EK0Z]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Skin
The Specific Disease Sensitive skin
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.778250493; Fold-change: -0.005586626; Z-score: -0.134955402
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
ICD Disease Classification 15
Click to Show/Hide the 6 Disease of This Class
Osteoarthritis [ICD-11: FA00-FA0Z]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Synovial
The Specific Disease Osteoarthritis
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.599844122; Fold-change: -0.103086567; Z-score: -0.216837057
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Arthropathy [ICD-11: FA00-FA5Z]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Peripheral blood
The Specific Disease Arthropathy
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.785369427; Fold-change: -0.008663818; Z-score: -0.056500574
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Arthritis [ICD-11: FA20]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Peripheral blood
The Specific Disease Arthritis
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.000446547; Fold-change: 0.152238645; Z-score: 0.606474752
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Rheumatoid arthritis [ICD-11: FA20]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Synovial
The Specific Disease Rheumatoid arthritis
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.565643772; Fold-change: -0.124030352; Z-score: -0.180244594
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Ankylosing spondylitis [ICD-11: FA92.0Z]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Pheripheral blood
The Specific Disease Ankylosing spondylitis
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.044832891; Fold-change: -0.139964854; Z-score: -1.332955578
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Osteoporosis [ICD-11: FB83]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Bone marrow
The Specific Disease Osteoporosis
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.859618754; Fold-change: 0.281041969; Z-score: 0.299172031
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
ICD Disease Classification 16
Click to Show/Hide the 2 Disease of This Class
Endometriosis [ICD-11: GA10]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Endometrium
The Specific Disease Endometriosis
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.883536692; Fold-change: 0.022824831; Z-score: 0.080629273
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Interstitial cystitis [ICD-11: GC00.3]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Bladder
The Specific Disease Interstitial cystitis
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.002032443; Fold-change: 0.295260568; Z-score: 2.274319635
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
ICD Disease Classification 19
Click to Show/Hide the 1 Disease of This Class
Preterm birth [ICD-11: KA21.4Z]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Myometrium
The Specific Disease Preterm birth
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.042769547; Fold-change: -0.23289768; Z-score: -0.88558886
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
ICD Disease Classification 2
Click to Show/Hide the 8 Disease of This Class
Acute myelocytic leukemia [ICD-11: 2A60]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Bone marrow
The Specific Disease Acute myelocytic leukemia
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 4.07E-15; Fold-change: 0.119651191; Z-score: 0.57864228
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Myeloma [ICD-11: 2A83]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Bone marrow
The Specific Disease Myeloma
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.022460893; Fold-change: 0.169054939; Z-score: 0.818982916
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
The Studied Tissue Peripheral blood
The Specific Disease Myeloma
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.908750874; Fold-change: 0.143886814; Z-score: 0.10180355
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Oral cancer [ICD-11: 2B6E]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Oral
The Specific Disease Oral cancer
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.007228515; Fold-change: -0.215545871; Z-score: -0.543880304
The Expression Level of Disease Section Compare with the Adjacent Tissue p-value: 0.000166678; Fold-change: 0.19945083; Z-score: 0.583791451
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Esophagal cancer [ICD-11: 2B70]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Esophagus
The Specific Disease Esophagal cancer
The Expression Level of Disease Section Compare with the Adjacent Tissue p-value: 0.645077252; Fold-change: -0.092107949; Z-score: -0.528294333
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Rectal cancer [ICD-11: 2B92]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Rectal colon
The Specific Disease Rectal cancer
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.720450651; Fold-change: -0.011888992; Z-score: -0.092315299
The Expression Level of Disease Section Compare with the Adjacent Tissue p-value: 0.378679409; Fold-change: 0.103319986; Z-score: 0.379697184
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Skin cancer [ICD-11: 2C30-2C3Z]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Skin
The Specific Disease Skin cancer
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 9.18E-15; Fold-change: -0.60670709; Z-score: -1.042532844
The Expression Level of Disease Section Compare with the Adjacent Tissue p-value: 4.32E-09; Fold-change: 0.399857001; Z-score: 0.73247132
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Renal cancer [ICD-11: 2C90-2C91]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Kidney
The Specific Disease Renal cancer
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 1.53E-09; Fold-change: 0.760442618; Z-score: 2.838597859
The Expression Level of Disease Section Compare with the Adjacent Tissue p-value: 1.55E-15; Fold-change: 0.530662477; Z-score: 1.223808077
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Ureter cancer [ICD-11: 2C92]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Urothelium
The Specific Disease Ureter cancer
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.691774325; Fold-change: 0.024357467; Z-score: 0.111240685
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
ICD Disease Classification 20
Click to Show/Hide the 2 Disease of This Class
Simpson golabi behmel syndrome [ICD-11: LD2C]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Adipose
The Specific Disease Simpson golabi behmel syndrome
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.326468562; Fold-change: 0.058558833; Z-score: 0.529156537
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Tuberous sclerosis complex [ICD-11: LD2D.2]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Perituberal
The Specific Disease Tuberous sclerosis complex
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.67771948; Fold-change: 0.004732237; Z-score: 0.047335724
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
ICD Disease Classification 3
Click to Show/Hide the 3 Disease of This Class
Anemia [ICD-11: 3A00-3A9Z]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Bone marrow
The Specific Disease Anemia
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.025303891; Fold-change: 0.187789279; Z-score: 1.067160433
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Sickle cell disease [ICD-11: 3A51.0-3A51.3]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Peripheral blood
The Specific Disease Sickle cell disease
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.72619028; Fold-change: 0.148298157; Z-score: 0.485448848
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Thrombocythemia [ICD-11: 3B63]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Whole blood
The Specific Disease Thrombocythemia
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.785294764; Fold-change: -0.031117895; Z-score: -0.163755511
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
ICD Disease Classification 4
Click to Show/Hide the 4 Disease of This Class
Scleroderma [ICD-11: 4A42.Z]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Whole blood
The Specific Disease Scleroderma
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.453749139; Fold-change: -0.035554451; Z-score: -0.164904834
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Sjogren syndrome [ICD-11: 4A43]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Salivary gland
The Specific Disease Sjogren syndrome
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.388523644; Fold-change: -0.025261953; Z-score: -0.240341034
The Expression Level of Disease Section Compare with the Adjacent Tissue p-value: 0.100650162; Fold-change: -0.263039421; Z-score: -1.48428833
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Behcet disease [ICD-11: 4A62]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Peripheral blood
The Specific Disease Behcet disease
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.084057543; Fold-change: -0.090100616; Z-score: -0.479130433
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Autosomal dominant monocytopenia [ICD-11: 4B04]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Whole blood
The Specific Disease Autosomal dominant monocytopenia
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.857148566; Fold-change: 0.027523232; Z-score: 0.159531958
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
ICD Disease Classification 5
Click to Show/Hide the 5 Disease of This Class
Type 2 diabetes [ICD-11: 5A11]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Liver
The Specific Disease Type 2 diabetes
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.810479208; Fold-change: -0.038589129; Z-score: -0.300335612
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Polycystic ovary syndrome [ICD-11: 5A80.1]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Vastus lateralis muscle
The Specific Disease Polycystic ovary syndrome
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.22461013; Fold-change: -0.064156387; Z-score: -0.402103219
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Obesity [ICD-11: 5B81]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Subcutaneous Adipose
The Specific Disease Obesity
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.701099178; Fold-change: 0.044226419; Z-score: 0.150109647
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Pompe disease [ICD-11: 5C51.3]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Biceps muscle
The Specific Disease Pompe disease
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.19172148; Fold-change: -0.212133177; Z-score: -1.137335211
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Batten disease [ICD-11: 5C56.1]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Whole blood
The Specific Disease Batten disease
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.53945386; Fold-change: 0.007080026; Z-score: 0.087764489
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
ICD Disease Classification 6
Click to Show/Hide the 2 Disease of This Class
Autism [ICD-11: 6A02]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Whole blood
The Specific Disease Autism
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.027437606; Fold-change: -0.133990608; Z-score: -0.631734306
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Anxiety disorder [ICD-11: 6B00-6B0Z]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Whole blood
The Specific Disease Anxiety disorder
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.251525355; Fold-change: -0.011369707; Z-score: -0.04812893
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
ICD Disease Classification 8
Click to Show/Hide the 7 Disease of This Class
Parkinson disease [ICD-11: 8A00]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Substantia nigra
The Specific Disease Parkinson disease
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.816749426; Fold-change: 0.051519886; Z-score: 0.177510847
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Huntington disease [ICD-11: 8A01]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Whole blood
The Specific Disease Huntington disease
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.896760134; Fold-change: 0.043644093; Z-score: 0.195416356
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Alzheimer disease [ICD-11: 8A20]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Entorhinal cortex
The Specific Disease Alzheimer disease
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.54206812; Fold-change: -0.021169133; Z-score: -0.150616497
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Seizure [ICD-11: 8A60-8A6Z]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Whole blood
The Specific Disease Seizure
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.584043066; Fold-change: 0.023330874; Z-score: 0.11344192
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Lateral sclerosis [ICD-11: 8B60.4]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Skin
The Specific Disease Lateral sclerosis
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.884547504; Fold-change: 0.042495384; Z-score: 0.254134797
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
The Studied Tissue Cervical spinal cord
The Specific Disease Lateral sclerosis
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.002169567; Fold-change: 0.244236706; Z-score: 1.492422026
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Muscular atrophy [ICD-11: 8C70]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Muscle
The Specific Disease Muscular atrophy
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 3.68E-06; Fold-change: -0.504548695; Z-score: -2.217506406
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Myopathy [ICD-11: 8C70.6]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Muscle
The Specific Disease Myopathy
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.042628875; Fold-change: -0.279224546; Z-score: -1.490340166
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
References
Ref 1 First-in-human multicenter phase I study of BMS-936561 (MDX-1203), an antibody-drug conjugate targeting CD70. Cancer Chemother Pharmacol. 2016 Jan;77(1):155-62.
Ref 2 Design, Synthesis, and Structure-Activity Relationships of Novel Tetrahydroisoquinolino Benzodiazepine Dimer Antitumor Agents and Their Application in Antibody-Drug Conjugates. J Med Chem. 2020 Nov 25;63(22):13913-13950. doi: 10.1021/acs.jmedchem.0c01385.
Ref 3 Benzodiazepine dimers, conjugates thereof, and methods of making and using.
Ref 4 Phosphate based linkers for intracellular delivery of drug conjugates; 2015-10-08.
Ref 5 Beta-glucuronide-linker drug conjugates; 2007-10-25.
Ref 6 Methylene carbamate linkers for use with targeted-drug conjugates; 2015-06-25.
Ref 7 Cyclodextrin and antibody-drug conjugate formulations.
Ref 8 Novel peptide linkers for highly potent antibody-auristatin conjugate. Bioconjug Chem. 2008 Oct;19(10):1960-3. doi: 10.1021/bc800289a. Epub 2008 Sep 20.
Ref 9 Introduction to basic information on ADC drug Alpha-CD70-Mc-MMAF
Ref 10 A phase 2 study of the cytotoxic immunoconjugate CMB-401 (hCTM01-calicheamicin) in patients with platinum-sensitive recurrent epithelial ovarian carcinoma. Cancer Immunol Immunother. 2003 Apr;52(4):243-8.
Ref 11 CD70 antibody-drug conjugate as a potential therapeutic agent for uterine leiomyosarcoma. Am J Obstet Gynecol. 2021 Feb;224(2):197.e1-197.e23. doi: 10.1016/j.ajog.2020.08.028. Epub 2020 Aug 19.
Ref 12 Hydrophilic antibody-drug conjugates; 2015-08-20.
Ref 13 Phase I dose-escalation study of SGN-75 in patients with CD70-positive relapsed/refractory non-Hodgkin lymphoma or metastatic renal cell carcinoma. Invest New Drugs. 2014 Dec;32(6):1246-57. doi: 10.1007/s10637-014-0151-0. Epub 2014 Aug 22.
Ref 14 PRO1160, a novel CD70-directed antibody-drug conjugate, demonstrates robust anti-tumor activity in mouse models of renal cell carcinoma and non-Hodgkin lymphoma. Cancer Res (2022) 82 (12_Supplement): 1759.
Ref 15 Ambrx biopharmaceutical company product pipeline.
Ref 16 Discovery of Pyrophosphate Diesters as Tunable, Soluble, and Bioorthogonal Linkers for Site-Specific Antibody-Drug Conjugates. J Am Chem Soc. 2016 Feb 3;138(4):1430-45. doi: 10.1021/jacs.5b12547. Epub 2016 Jan 25.
Ref 17 Introduction to basic information on anti-CD70 antibody-drug conjugate(XDCExplorer).
Ref 18 A phase 1 trial of SGN-CD70A in patients with CD70-positive, metastatic renal cell carcinoma. Cancer. 2019 Apr 1;125(7):1124-1132. doi: 10.1002/cncr.31912. Epub 2019 Jan 9.

If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.